Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Automation In Biopharma Industry Market Expected To Reach $3.15 Billion By 2030 At 7.7% CAGR

The biopharmaceutical sector’s automation market has witnessed robust expansion, projected to increase from $2.19 billion in 2025 to $2.35 billion in 2026, reflecting a compound annual growth rate of 7.1%. This upward trajectory during the historical period is underpinned by several key factors, including the escalating complexity associated with biologic drug manufacturing, a growing need for scalable biopharmaceutical production capabilities, the early embracement of laboratory automation solutions, the proliferation of contract manufacturing services, and significant advancements in process control technologies.

The biopharmaceutical sector’s automation market is poised for significant expansion, projecting a valuation of $3.16 billion by 2030, reflecting a compound annual growth rate of 7.7%. This anticipated surge is fueled by escalating investments in intelligent biomanufacturing infrastructure, the wider embrace of continuous production methods, advancements in personalized biologic manufacturing, a heightened need for regulatory adherence in automation, and a concentrated effort to refine manufacturing output. Key developments shaping this period include the increasing deployment of automated production systems, the greater incorporation of digital twin methodologies, the expanded utilization of automated quality assurance processes, comprehensive automation across bioprocessing, and a stronger emphasis on manufacturing guided by data analytics.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

#Automation In Biopharma Industry Market Growth Drivers And Industry Catalysts

The expanding utilization of robotic systems within the pharmaceutical production sector is anticipated to be a significant catalyst for the advancement of the automation in the biopharma industry market. These sophisticated automated systems and machinery are instrumental in executing diverse functions throughout the creation and packaging of medicinal goods. Their application spans numerous facets of pharmaceutical manufacturing, including but not limited to, secondary packaging operations, internal logistics management, laboratory process automation, pick-and-place activities, the streamlining of pharmacy workflows, and the development of personalized medicines. Such widespread deployment leads to substantial improvements in productivity, elevates precision levels, minimizes contamination risks, and bolsters the safety of the workforce. Illustrating this trend, September 2024 data from the International Federation of Robotics, a renowned German non-profit entity, indicated a robust 9% surge in industrial robot installations across Europe’s manufacturing landscape, achieving an all-time peak of 92,393 units. Notably, a substantial 80% of these installations, amounting to 73,534 units, were situated within the European Union, reflecting a 2% year-over-year increase. Consequently, the escalating integration of robots in pharmaceutical manufacturing is poised to propel the expansion of the automation in biopharma industry market.

Automation In Biopharma Industry Market Segment Breakdown: Which Categories Generate The Most Revenue?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

#Automation In Biopharma Industry Market Trends Influencing Long-Term Demand

Within the biopharmaceutical sector, leading enterprises are actively driving automation initiatives, specifically targeting the enhancement of technological capabilities like robotic platforms designed for cell-therapy production. These advanced systems are engineered to achieve large-scale, highly efficient, and accuracy-improved manufacturing of sophisticated therapies. A typical robotic cell-therapy manufacturing setup integrates autonomous mobile units, sterile liquid management tools, automated pipe joining mechanisms, and digitized workflow oversight, creating a completely sealed and adaptable environment. This stands in stark contrast to conventional manual bioprocessing methods, which are considerably labor-intensive and utilize open containment strategies. As an illustration, in May of 2023, Cellular Origins, a UK entity specializing in life sciences automation, introduced Constellation, an adaptable robotic framework intended for the creation of cutting-edge therapies. This platform features integrated autonomous mobile robots, aseptic liquid conveyance systems, and modular processing stations, facilitating smooth incorporation into established bioprocessing operations. It achieves a remarkable 30-fold improvement in spatial utilization, necessitates 16 times less human effort, and slashes manufacturing expenses by 51%, all while providing comprehensive digital connectivity for quality assurance and remote oversight.

Automation In Biopharma Industry Market Key Players And Strategic Industry Positioning

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Access The Complete Automation In Biopharma Industry Market Report:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Automation In Biopharma Industry Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model